Prostate News Archive
21-Jan-2009
Improved PSA Tests a Better Gauge of Prostate Cancer Risk (Newswise)
A prostate-specific antigen (PSA) test can't diagnose prostate cancer, but results indicate the risk of cancer. According to the January issue of Mayo Clinic Health Letter, recent fine-tuning of this test gives doctors better information to help determine cancer risk. Determinants Of PSA Change Over Time And Its Link To Recurrence After External Beam Radiation Therapy For Prostate ... (Medical News Today)
UroToday.com - Following external-beam radiation therapy, many criteria based on prostate-specific antigen (PSA) measurements are known to be associated with the risk of clinical disease progression when examined in large cohorts. The Genetic Fingerprint Of Prostate Cancer - How Estrogen Might Play A Role (Medical News Today)
One in six American men are diagnosed with prostate cancer within their lifetime and 186,000 will be diagnosed this year. For most men, their disease is confined to the prostate gland, making it easier to treat and less lethal. However, some unfortunate patients suffer from a more aggressive cancer that metastasizes, or spreads beyond the boundaries of the prostate gland. Hormel Institute gets $1 million grant for prostate cancer study (Pioneer Press)
ROCHESTER, Minn. ? A $1 million federal grant is going to the Hormel Institute to study an herbal compound's ability to help prevent prostate cancer. Prostate cancer pioneer and former prof. dies (The Minnesota Daily)
Dr. Donald Gleason. In medicine, technological advances and breakthroughs happen at lightning-paced speeds. But in the realm of prostate cancer, one major development, the Gleason grading system for tumors, has stood the test of time. The man who developed the grading scale in 1966, Dr. Donald Gleason, died of heart failure on Dec. 28. read more
Back to Prostate News Archive
